Products Liability Suit Targets Those Responsible For Opioid Epidemic.

Drug addiction can have enormous effects on one’s mental and physical health. It is an overarching issue that the American public has struggled with for some time. The current opioid epidemic is not only ruining the lives of individuals, but also tearing whole communities apart, causing incalculable damage to the well-being of citizens across the nation. The city of Los Angeles, for its part, has decided that those who have contributed to the opioid epidemic must face consequences for their negligent handling of the situation and has filed suit.

According to the allegations of the complaint, several opioid manufacturers have engaged in marketing activity that has contributed significantly to the epidemic. The lawsuit includes allegations that certain manufacturers, which include Purdue Pharma LP and Endo Pharmaceuticals, failed to report suspicious orders and misled medical professionals about the risks associated with opioids. Attorney Mike Feuer believes that the mismanagement of opioid information and negligent marketing practices have resulted in severe over-prescription of opioids, which in turn creates a dangerous dependency.

Drug addiction is not always the fault of the individual. If you or a loved one has been subject to negligent practices by your doctor or the drug manufacturer itself, you may be entitled to significant monetary relief. To discuss your potential products liability suit, act now and contact one of our expert products liability attorneys here at the Law Offices of Gilbert R. Hoy, Jr. and Affiliates. Call us today at 617-787-3700 or email us at info@gilhoylaw.com for your free and private consultation. Your needs are our top priority!

This entry was posted in Boston Medical Malpractice Lawyer, Boston Medication Error Lawyer, Boston Personal Injury Lawyer, Boston Product Liability Lawyer, Boston Wrongful Death Lawyer. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *